NR1I2 and breast cancer: Another study by Nagaoka reported that tamoxifen activates CYP3A4 and MDR1/P-glycoprotein genes through steroid and xenobiotic receptor (SXR), a member of nuclear hormone receptors, which may affect tamoxifen metabolism and transport in breast cancer cells [27].